{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-25-009063","form_type":"8-K","ticker":"BBIO","cik":"0001743881","company_name":"BridgeBio Pharma, Inc.","filed_at":"2025-03-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.688356+00:00","generated_at":"2026-05-24T15:56:05.048667+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"BridgeBio Pharma appoints Thomas Trimarchi as President and CFO; former CFO departs","bullets":["Brian Stephenson's employment ended March 17, 2025; receives 9 months base salary and COBRA.","Stephenson to serve as consultant from March 17, 2025 through March 17, 2026.","Thomas Trimarchi appointed President and CFO; effective immediately.","Stephenson's departure is for personal reasons and not due to any disagreement with the company."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-25-009063","json":"https://secwatch.observer/filing/0001140361-25-009063.json","markdown":"https://secwatch.observer/filing/0001140361-25-009063.md","text":"https://secwatch.observer/filing/0001140361-25-009063.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1743881/000114036125009063/0001140361-25-009063-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1743881/000114036125009063/ef20045625_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T15:56:05.048667+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"fbec7d51d1","claim":"Brian C. Stephenson departed as Chief Financial Officer at BridgeBio Pharma, Inc..","evidence_excerpt":"The employment of Brian C. Stephenson, the Chief Financial Officer of BridgeBio Pharma, Inc. (the “Company”), ended on March 17, 2025 (the “Effective Date”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1743881/000114036125009063/0001140361-25-009063-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"ended"},{"label":"Role","value":"Chief Financial Officer"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}